贝达基林,线索利德,克洛法西明"核心"对多药耐药结核病的有效性
C Zeng1, M A Hernán2, L Trevisi1
1Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.
IJTLD open
|May 14, 2025
概括
对于具有诺基诺隆 (FQ) 耐药性的多药耐药结核病 (MDR-TB),强化治疗方案的成功率略高. 需要进一步的研究来优化在这些具有挑战性的病例中最大限度地提高治疗成功的策略.
科学领域:
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 当诺基诺 (FQ) 耐药性存在时,多药/瑞芬耐药结核病 (MDR/RR-TB) 的治疗结果通常很差.
- 使用包括贝达基林 (Bdq),线索利德和克洛法西明在内的个性化疗法,但由于FQ抵抗,有效性可能会受到损害.
研究的目的:
- 为了比较标准的个性化治疗方案的有效性与那些用特定药物强化或延长贝达基林 (Bdq) 持续时间的患者在FQ耐药的MDR/RR-TB.
- 评估在一个难以治疗的患者群体中改善治疗成功率的策略.
主要方法:
- 使用模拟向试验设计来比较不同的治疗方案.
- 克隆,审查和反向概率权重被用来估计成功治疗结果的概率.
主要成果:
- 经调整后,治疗成功的概率在0.75到0.84.4之间.
- 用贝达基林 (Bdq) 强化治疗方案≥9个月,德拉曼尼德 (Dlm) 或伊米佩内姆 (Imp) 显示治疗成功率略高,但置信区间很宽,表明不准确.
结论:
- 一些强化治疗方案显示,FQ抗性MDR/RR-TB的治疗成功率略有增加.
- 需要进行进一步的研究,以确定和验证最佳策略,以最大限度地提高基诺耐药患者的治疗成功率.
更多相关视频
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
7.7K
09:57Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
Published on: December 14, 2016
10.4K
相关概念视频
Pulmonary Tuberculosis V
159
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
159
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
Pulmonary Tuberculosis I
214
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
214
Pulmonary Tuberculosis IV
127
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
127
Psychosis: Goals of Pharmacotherapy
101
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
101
Pulmonary Tuberculosis III
283
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
283
